Eton Pharmaceuticals (ETON) SEC Filings & 10K Form

$3.22
+0.01 (+0.31%)
(As of 10:45 AM ET)

Recent Eton Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/18/2024
3:22 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:24 PM
Eton Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/22/2024
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
3:15 PM
Eton Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:16 PM
Eton Pharmaceuticals (Issuer)
MAIER PAUL V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:17 PM
Eton Pharmaceuticals (Issuer)
Krempa David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:18 PM
CASAMENTO CHARLES J (Reporting)
Eton Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
BRYNJELSEN SEAN (Reporting)
Eton Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
Adams Jennifer McKie (Reporting)
Eton Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:21 PM
Eton Pharmaceuticals (Issuer)
Gruber James R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:25 PM
Eton Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2023
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:18 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
3:15 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
5:50 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
11:15 PM
Eton Pharmaceuticals (Filer)
Form EFFECT
04/27/2023
3:30 PM
Eton Pharmaceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ETON) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners